Lindy P. Fox

Guest Editor for the following articles:

Dec
2006
Vol. 25. No. 4

The Changing Face of Graft-Versus-Host Disease

Julie V. Schaffer, MD

Despite advances in the procedure and posttransplantation immunosuppressive therapy, more than half of allogeneic hematopoietic stem cell transplant (HSCT) recipients develop graft-versus-host disease (GVHD), which remains a major cause of morbidity and mortality.

MORE
Sep
2007
Vol. 26. No. 3

Approach to the Morbilliform Eruption in the Hematopoietic Transplant Patient

Dimitrios P. Kontoyiannis, MD | Elizabeth Truong | Joy H. Kunishige, MD | Sharon R. Hymes, MD | Steven R. Mays, MD

The onset of a morbilliform eruption in the posttransplant period presents a diagnostic dilemma. Not only is the morphology nonspecific, but there are also no definitive diagnostic tests that differentiate one etiology from another. In addition, histopathology may be nonspecific.

MORE
Dec
2006
Vol. 25. No. 4

Emerging Infections in Dermatology

J Mark Jackson, MD

This review will focus on 3 of these emerging infections: community acquired methicillin-resistant Staphylococcus aureus (MRSA), Epstein Barr virus cutaneous infections, and the reemergence of atypical mycobacterial infections.

MORE
Mar
2014
Vol. 33. No. 1

Severe drug-induced dermatoses

Iris Ahronowitz, MD | Lindy P. Fox, MD

A variety of common dermatoses are known to have
drug-induced variants. This article discusses the clinical
presentation, time frames, reported culprit medications,
pathophysiology and management of drug-induced
lupus, cutaneous vasculitis, pemphigus, pemphigoid,
linear IgA bullous dermatosis, Sweet’s syndrome, erythema
nodosum, pyoderma gangrenosum, pseudolymphoma,
lichen planus, and psoriasis.

MORE
Mar
2017
Vol. 36. No. 1

The role of dermatopathology in inpatient care

Cuong V Nguyen, MD | Daniel D Miller, MD

Increasing downward financial pressure and decreasing hospital stay durations make the efficient practice of hospital dermatology and dermatopathology all the more important for patients.

MORE